BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice. Initially discovered in the 1990s, this peptide has garnered significant attention in research circles for its apparent tissue-protective and healing properties. Animal studies suggest BPC-157 may accelerate wound healing, reduce inflammation, and protect various organs including the gastrointestinal tract, tendons, muscles, and even neural tissue.

The research on BPC-157 is primarily limited to animal models and in vitro studies, with only a handful of small human trials conducted to date. Studies indicate the peptide may work through multiple mechanisms including promotion of angiogenesis (blood vessel formation), modulation of growth factors, and interaction with various neurotransmitter systems. Animal research has shown promising results for treating ulcers, tendon injuries, and even some neurological conditions, though the translation of these effects to humans remains largely unproven.

Despite limited human clinical data, BPC-157 has gained popularity in biohacking and athletic communities, often used off-label for injury recovery and performance enhancement. The peptide exists in a regulatory gray area in most countries, typically available as a research chemical rather than an approved therapeutic agent. Quality and purity can vary significantly between suppliers, and long-term safety data in humans is virtually non-existent, making careful consideration essential before use.